Unaudited Financial results for the Six Months ended September
30,2003
Rs. Lakhs
Sl. No
Particulars
Three Months Ended 30.09.2003
(Uaudited)
Three Months Ended
30.09.2002
(Unaudited)
Six Months Ended
30.09.2003
(Unaudited)
Six Months Ended
30.09.2002
(Unaudited)
Year Ended 31.03.2003
(Audited)
1
Sales & Operating Income
16183.32
11133.26
33475.39
21816.76
54141.43
2
Other Income
14.69
28.27
64.58
30.87
111.38
3
Total Expenditure
12288.35
8914.33
26321.63
17392.04
43289.70
a) Decrease/(Increase)in stock in trade
(1985.78)
(3320.34)
(3161.82)
(3459.56)
(4702.99)
b) Consumption of raw materials
9305.15
8109.01
19872.53
13679.55
31910.92
c) Staff Cost
1208.82
765.27
2169.23
1518.69
3403.16
d) Other Expenditure
3760.16
3360.39
7441.69
5653.36
12678.61
4
Profit before Interest,
Depreciation & Tax (1+2-3)
3909.66
2247.20
7218.34
4455.59
10963.11
5
Interest & Finance Charges
1660.88
1032.99
2769.58
1789.61
4207.69
6
Depreciation
1350.15
867.98
2730.21
1890.73
4030.71
7
Profit before tax (4-5-6)
898.63
347.23
1718.55
775.25
2724.71
8
Provision for Taxation
-Current Tax
36.96
-
100.05
-
-Deferred Tax
131.60
57.06
131.60
195.33
770.65
9
Net Profit (7-8)
730.07
289.17
1486.90
579.92
1954.06
10
Paid-Up Equity Share Capital (Face value of Rs.10/- each)
3238.19
2799.92
3238.19
2799.92
3238.19
11
Reserves excluding Revaluation Reserves
-
-
36990.13
12
Basic & Diluted
Earnings per Share (Rs.)
2.25*
1.03*
4.59*
2.07*
6.61
13
Aggregate
of Non - Promoter Shareholding
-Number of equity shares
of Rs.10 each
27552762
23413322
27552762
23413322
27640677
-Percentage of Shareholding
85.09
83.62
85.09
83.62
85.36
* EPS is
for the period (not annualised) after providing for deferred tax
SEGMENT
WISE REVENUE, RESULTS AND CAPITAL EMPLOYED
(Rs.Lakhs)
Particulars
Three Months Ended
30-09-03
Three Months Ended
30-09-02
Six Months Ended
30-06-03
Six Months Ended
30-06-02
Year Ended
31-03-03
1. Segment Revenue
a. Bulk
13911.40
10279.32
29214.09
20004.05
50066.25
b. Formulations
2803.08
1452.25
5584.81
2638.76
6346.07
Total
16714.48
11731.57
34798.90
22642.81
56412.32
Less: Inter segment revenue
531.16
598.31
1323.51
826.05
2270.89
Net Sales / Income from Operations
16183.32
11133.26
33475.39
21816.76
54141.43
2. Segment Results
(Profit/(Loss) before interest and tax)
a. Bulk
2570.45
1172.48
4211.97
2369.08
7315.15
b. Formulations
(25.63)
179.04
211.58
165.48
(452.40)
Total
2544.82
1351.52
4423.55
2534.56
6862.75
Less:
i) Interest (Net)
1660.88
1032.99
2769.58
1789.61
4207.69
ii) Other unallocable
expenditure net of unallocable income
(14.69)
(27.70)
(64.58)
(30.30)
(69.65)
Total Profit Before Tax
898.63
346.23
1718.55
775.25
2724.71
3. Capital Employed
a. Bulk
121420.47
75540.53
121420.47
75540.53
98935.81
b. Formulations
9561.58
4202.84
9561.58
4202.84
9350.00
Total
130982.05
79743.37
130982.05
79743.37
108285.81
1
The Company received 14 complaints during
the quarter ended December 31, 2003 from the shareholders, all the
complaints have been resolved and no complaints were pending as
on December 31,2003.
2
Previous period figures have been regrouped
wherever necessary.
3
During the quarter, the Company received approval from the US
FDA for its sterile lyophilized product, Cefazolin produced at
its Alathur facility.
4
The statutory auditors carried
out limited review of the financial results and the results were
taken on record by the Board of Directors at its meeting held on
Thursday, January 15, 2004
Unaudited Financial results for the Three Months ended
June 30,2003
Rs. Lakhs
Sl. No
Particulars
Three Months Ended 30.06.2003
(Unaudited)
Three Months Ended
30.06.2002 (Unaudited)
Year Ended 31.03.2003 (Audited)
1
Sales & Operating Income
17292.07
10683.50
54141.43
2
Other Income
49.89
2.60
111.38
3
Total Expenditure
14033.28
8477.70
43289.70
a) Decrease/(Increase)in stock in trade
(1176.04)
(139.22)
(4702.99)
b) Consumption of raw materials
10567.38
5570.54
31910.92
c) Staff Cost
960.41
729.01
3403.16
d) Other Expenditure
3681.53
2317.37
12678.61
4
Profit before Interest,
Depreciation & Tax (1+2-3)
3308.68
2208.40
10963.11
5
Interest & Finance Charges
1108.70
756.62
4207.69
6
Depreciation
1380.06
1022.76
4030.71
7
Profit before tax (4-5-6)
819.92
429.02
2724.71
8
Provision for Taxation
63.09
138.27
770.65
10
Net Profit (7-8)
756.83
290.75
1954.06
11
Paid-Up Equity Share Capital (Face value of Rs.10/- each)
3238.19
2799.92
3238.19
12
Reserves excluding Revaluation Reserves
36990.13
13
Basic & Diluted
Earnings per Share (Rs.)
2.34*
1.04*
6.61
* EPS is for the period
(not annualised)
SEGMENT
WISE REVENUE, RESULTS AND CAPITAL EMPLOYED
(Rs.Lakhs)
Particulars
Three Months Ended
30-06-03
Three Months Ended
30-06-02
Year Ended
31-03-03
1. Segment Revenue
a. Bulk
15302.69
9724.73
50066.25
b. Formulations
2781.73
1186.51
6346.07
Total
18084.42
1091.24
56412.32
Less: Inter segment revenue
792.35
227.74
2270.89
Net Sales / Income from Operations
17292.07
10683.50
54141.43
2. Segment Results
a. Bulk
1641.52
1196.60
7315.15
b. Formulations
237.21
(13.56)
(452.40)
Total
1878.73
1183.04
6862.75
Less:
i) Interest (Net)
1108.70
756.62
4207.69
ii) Other unallocable
expenditure net of unallocable income
(49.89)
(2.60)
(69.65)
Total Profit Before Tax
819.92
429.02
2724.71
3. Capital Employed
a. Bulk
102305.04
76741.71
98935.81
b. Formulations
9587.21
2823.36
9350.00
Total
111892.25
79565.07
108285.81
1
The above financial results were adopted
by the Board of Directors at its meeting held on Wednesday, July
24, 2003.
2
Previous period figures have been regrouped
wherever necessary.
3
The provisions of Income Tax Act, 1961
relating to EOU's have been amended on May 8, 2003. Pursuant to
this, the deferred tax iability for the quarter has been adjusted
against deferred tax assets available.
4
The Company received 20 complaints during
the quarter ended June30, 2003 from the shareholders, all the complaints
have been resolved and no complaints were pending as on June 30,
2003.
